Embracing Proactive Multi-Indication Development for Metabolic TherapiesByAlan Baldridge, MDAugust 15th 2025A 2025 survey highlights growing momentum for multi-indication drug development, with opportunities in innovative trial design, targeted patient selection, and real-world evidence to speed label expansion.